Bangalore, May 2021: Muthoot Finance is India’s largest gold loan NBFC. The company has initiated a COVID-19 vaccination support project through its mobile laboratory Muthoot Snehasraya in association with Myvacc.in team that will provide vaccination drives in Karnataka. ‘Muthoot Snehasraya’ is a CSR initiative of Muthoot Finance Ltd, intended for prevention, early detection and awareness of Kidney related diseases and for supporting dialysis patients by financial aid. MyVacc.in is a platform for vaccinations of children and adults at home, corporates at offices, communities and schools.
Muthoot Finance aims to help the underprivileged 45+ segment to get vaccinated and encourages vaccination to build a protective shield that will help in fighting against the second-wave of COVID-19. This initiative will be carried out free of cost.
Mr. George M Alexander Muthoot, Executive Director, Muthoot Finance said, “The core objective of Muthoot Finance Snehasraya project is to protect and get the underprivileged vaccinated for free. We will expand this vaccination project to other states in the upcoming months.”
Muthoot Finance is extending vaccination drives through Muthoot Snehasraya mobile laboratory with the help of Myvacc.in which will be providing COVID-19 vaccines at the doorstep across several areas in Karnataka.
~ Neuberg becomes the first lab chain of Indian origin to start direct operations in the USA with CLIA certified lab operations ~
~ Unites key collaborators under one umbrella for molecular and genomics based new generation testing ~
May 03, 2021: Neuberg Diagnostics, a global laboratory testing group, announced the start of its clinical laboratory operations in North Carolina in the United States of America (USA). The laboratory in North Carolina, known as NCGM, Inc. (Neuberg Centre for Genomic Medicine), will focus on genomic and molecular testing based on new generation sequencing techniques. It also runs an extensive network of labs in India, South Africa, and the UAE as well.
NCGM has introduced COVID-19 molecular testing to detect active SARS CoV-2 virus infections that is of immediate public health priority in North America, along with genome scale testing, such as Exome Sequencing, which is applicable across a variety of Rare Genetic Disease Testing (Inherited Diseases) from Newborn Screening to Oncology to Pediatric Care Setting.
Dr. GSK Velu, Chairman & Managing Director of Neuberg Diagnostics, said, “NCGM, USA will act as the laboratory and hub, aiding our operations in the North America. Through leveraging our collaborative efforts across our organization in India, South Africa, and UAE, and with our external partners, we aim to develop and provide the best-in-class affordable tests. As they are deployed, the accessibility and affordability of the tests will reduce disparity and benefit individuals across the board.”
Dr Sandip Shah, Executive Director Neuberg Diagnostics, said “NCGM, USA Sequencing services will be supported by in-house bioinformatics team and cutting-edge technologies which has been developed inhouse, and along with reputed partners. It will also support genetic research by leveraging our own extensive infrastructure in India, South Africa, and UAE.”
Dr. Andy Bhattacharjee, CEO, NCGM, USA, said, “The setup has comprehensive Genomic testing facility allowing large-scale clinical and research projects. With capacity to conduct more than 400 variety of tests, the center will conduct large-scale clinical diagnostics and genomics projects with greater sample volumes at an unprecedented depth and coverage of the genome. Currently we are offering Covid RT-PCR Testing Services at our NC Lab with home sample collection facilities in association with FexEx to help fight the pandemic in USA too. “
STAR INDIA LAUNCHES A NEW CAMPAIGN FOCUSSING ON THE REAL HD EXPERIENCE The TVC ‘SIRF DIKHAANE KE LIYE NAHI, DEKHNE MEIN BHI REAL HD EXPERIENCE’ will air across the Star India Network in 7 languages
Mumbai, April 30, 2021: Star India has launched a new network-wide television campaign (TVC) ‘SIRF DIKHAANE KE LIYE NAHI, DEKHNE MEIN BHI REAL ‘HD’ EXPERIENCE to build awareness among television lovers who, despite owning an HD TV and HD Set-Top Box (STB), continue to view their favourite Star channels in Standard Definition (SD).
Consumers often think that having an HD TV by itself provides the complete HD viewing experience, which is a myth the campaign aims to bust with a touch of humor. Based on the findings from a study conducted by Star India, only 25%* of consumers are aware of the fact that apart from having an HD TV and an HD Set-Top box they also need to subscribe to HD channels to get the complete HD viewing experience. The campaign also highlights the features of Star HD channels such as wider picture, 5x sharper picture, and 5.1 Dolby surround sound that help make the viewing experience far more superior and immersive, ‘Taaki aapka HD TV sirf ‘dikhaane’ ke liye hee nahi, dekhne mein bhi Real HD experience de!’
Gurjeev Singh Kapoor, President – TV Distribution, India and International, Star And Disney India, said, “At Star India, we have always focused on providing an unparalleled entertainment experience and value to our viewers. There is a huge potential to further increase affinity towards our content with the large portfolio of 26 Star HD channels across genres and languages; with a strong live cricketing calendar this year and VIVO IPL 2021 just around the corner, we want consumers to experience the sheer delight and stadium-like feeling that our HD channels can provide. It is the right time for consumers to enhance their viewing experience with a Star HD channel subscription. Hence, this campaign is aimed at bridging the awareness gap and in helping consumers realize the relevance of recharging their Star HD channels.”
The campaign is driven by a well-conceptualized film that draws a parallel to people’s innate habit of keeping things in their homes for show value rather than using it for their intended purpose. Owning a fancy, flat-screen HD TV is something that elevates the social status of an individual, and the campaign cheekily nudges the consumer to elevate the value of their HD TV ‘Apne HD TV Ka Naam Roshan Kijiye’ by subscribing to Star HD channels. The campaign will also feature some of the most loved characters from the Star India Network endorsing the Real HD experience.
*study conducted amongst decision maker in TV channel packs subscription across 10,000+ Pay TV households in 2019, across 69 towns **conditions apply
ANNEXURE Star Network offers a holistic range of HD channels across genres & languages.
Channel Genre Star Plus HD Hindi GEC Star Bharat HD Hindi GEC Star Gold HD Hindi Movies Star Gold Select HD Hindi Movies UTV HD Hindi Movies Star Jalsha HD Bengali GEC Jalsha Movies HD Bengali Movies Vijay HD Tamil GEC Star Suvarna HD Kannada GEC Asianet HD Malayalam GEC Star Movies HD English Movies Star World HD English GEC Star Movies Select HD English Movies Disney International HD English GEC Star Sports HD1 Sports Star Sports HD2 Sports Star Sports 1 HD Hindi Sports Star Sports Select HD1 Sports Star Sports Select HD2 Sports Maa HD Telugu GEC Maa Movies HD Telugu Movies Star Pravah HD Marathi GEC Baby TV HD Kids National Geographic HD Infotainment Nat Geo Wild HD Infotainment Fox Life HD Infotainment
Invented by well-known scientist Dr. Rajah Vijay Kumar, the world’s first virus-attenuation device aims to get life and businesses back to normal amidst the pandemic
The device is proven to disable the Coronavirus and Influenza virus strains in indoor spaces, which carry the highest risk of transmission
Shycocan is scientifically evidenced to attenuate/neutralise 99.9% of both airborne and surface-borne Coronavirus family and Influenza family of viruses
Shycocan also works on all current and future variants and mutants of these viruses, ensuring a safe environment for both B2B and B2C
NEW DELHI / April 27, 2021: Shycocan, a breakthrough virus-attenuation device invented and manufactured in India, has been launched in the UAE at the International Conference of Pharmacy & Medicine (ICPM) held at Sharjah. This marks the Middle East debut of the product, the first of its kind in the world, that is seeing a robust demand from institutional buyers across the world in times of the raging Coronavirus pandemic.
The cylindrical device, Shycocan, is scientifically evidenced to neutralise and help curb the spread of the Coronavirus and Influenza family of viruses in indoor spaces with 99.9% efficacy, enabling schools, colleges, homes and businesses like hospitals, hotels, offices, restaurants, auditoriums, transportation, retail and airports get back to normal and serve the customers in a safe environment.
Remarkably, Shycocan also works on all current and future variants and mutants of these viruses, protecting people’s health and saving millions of hours of lost productivity.
Alok Sharma, Chief Executive Officer, Shycocan Corporation, said, “The world faced one of its biggest challenges with the pandemic, bringing us all to a standstill. More livelihoods than lives have been lost, in fact, close to a billion at the last count. Science, technology and innovation are going to play a big role in helping us reclaim our lives and work safely. We are delighted to launch the pathbreaking one- of-a-kind virus-attenuation device, the Shycocan, in the UAE in the hope of helping people bring lives and businesses back to normal. And we couldn’t have found a more credible and relevant platform than the prestigious ICPM to showcase our cutting-edge technology.”
Shycocan is distributed in the UAE for consumers and business customers by Redington Middle East LLC and Ibn Batuta Medicine & Medical Equipment Store LLC. It is one of the most thoroughly tested devices for both safety and efficacy. It neither uses nor emits radiation, chemicals, ozone or any toxic material. It is 100% safe for humans, animals and the environment. Additionally, it does not harm the bacterial ecosystem and microbes that thrive in the environment and are essential for our immunity.
Said the well-known scientist Dr. Rajah Vijay Kumar, the inventor of Shycocan,“Coronavirus-type outbreaks are occurring with faster intermittent frequencies. The COVID-19 strain is getting more infectious and deadlier with successive mutations in the last 17 years, underscoring the importance of a device like Shycocan. The biggest challenge of this virus is its infectivity or virulence. Breaking the chain of infectivity requires focused work on indoor environments because they carry the highest risk of transmission. In 2017, our campus in Bengaluru experienced many incidents of seasonal flu, compelling me to design, build and install the device which was later christened Shycocan. A year later, the incidence of seasonal flu was almost totally absent from the campus. When the COVID-19 pandemic struck, the device was sent for testing and regulatory compliances to global laboratories and found to be equally effective against it. It was overwhelming to realise that we had already created the world’s first technology to fight the pandemic long before imagining the possibility of such a crisis taking the entire world in its grip.”
Shycocan has widespread usage across market segments, including hospitals, clinics, schools, higher education institutions, banking sector, manufacturing and retail outlets, hospitality sector, government offices, real estate corporations and businesses. In addition, the company offers customised consultations, a one-year replacement warranty, strong support and service network across the UAE, and a post-installation audit.
A single device when mounted has an effective coverage area of 1,000 square feet (10,000 cubic feet). Multiple devices can be installed to cover a larger indoor space. The device has seen a robust demand from institutional buyers across the globe and is already in use in countries such as India, the US, Europe, Malaysia, Australia, New Zealand and South Africa, among others.
Dr Abdullah Al Kindi, Chairman & CEO, ICPM, said, “Mankind is facing one of the most challenging times – something that has impacted lives, livelihoods and businesses at a global scale. We as global citizens need the best of science, technology, social responsibility, and willpower to fight it – and triumph. ICPM was established with responsibility towards humanity and with healthcare as its foundation. It gives me immense pleasure to launch Shycocan on this platform. It is a product with innovative technology and the capability to bring businesses and lives back to normal.”
28 April 2021: Even as the daily caseload of India’s coronavirus infections, during the second wave, exceeds more than two lakhs, Shield30, a disruptive sanitization technology, is launched in India. This revolutionary, water-based antimicrobial surface treatment technology from New Zealand provides 99.99% protection from surface-borne infection of Coronaviruses and a host of other pathogens.
Surface transmission continues to pose a significant risk, as the Covid virus spreads through contaminated surfaces, known as fomites. Studies show that SARS-CoV-2 can persist on plastic and stainless steel for up to 6 days. It lasts for days on any hard materials including books, textile products – synthetic or natural made, and even on surgical masks. Hence, frequent disinfection of surfaces and objects in common places that are routinely used by several people is important. The need of the hour also is a breakthrough in the methods of disinfection that replaces chemical based sanitizers, which are harmful for the environment, and are also not very safe for people, children and pets.
As opposed to the conventional, chemical-based sanitizers, Shield30 is a water-based solution and contains no harmful chemicals or alcohol. It is safe for use near people, animals, and plants. Shield30 does not rely on dehydration or poison to kill pathogens. Instead, it forms a covalent bond, which resembles a layer of millions of nano-sized “pins”, on the surfaces and other frequently used things like doorknobs, chairs, and medical equipment. The pins attract the pathogens including coronaviruses and a host of other bacteria, mold, and fungi, and pierce and rupture their cellular structures and kill them. For each application, the protection lasts for nearly 30 days.
One of the prominent users of Shield30 is Meenakshi Mission Hospital and Research Centre, Madurai. Dr. S. Gurushankar, its chairman said that Shield30 provides 99.99% protection for patients, doctors, and staff against surface-borne infection of viruses, germs and bacteria. The hospital covers its entire premises right from the reception to operation theatres with Shield30 disinfectant solution. Medically, a big benefit of the ‘physical’ killing approach of Shield30 is that for the pathogens there is nothing to learn and develop their resistance and become superbugs, over time.
Shield30 can play a key role in reducing the economic impact of the Covid-19 pandemic, when the manufacturing and services industries, especially the travel, hospitality, restaurant, and hospital units, use it as their disinfectant solution.
In many countries in Europe and North America, restaurants are fumigated with Shield30 in order to destroy any traces of the virus, and thus attract customers. In a Shield30-sanitized restaurant if a customer walks in with coronavirus it would be killed as soon as he or she touches anything in it. Major aircraft now use Shield30 disinfectant with a focus on high contact areas – seats, seatbelts, overhead lockers, air vents and toilets.
Shield30 is certified by over 100 international labs for its effectiveness in killing the virus. Shield30 disinfectant solutions can be bought from all ecommerce platforms such as Amazon, Flipkart and Shield30 website (www.shield30.in), retail stores like pharmacy outlets, premium markets, hypermarkets and malls
City Today News 
You must be logged in to post a comment.